1355241-50-7

Basic information

• Product Name: 5-BroMo-2-chloro-thiazolo[5,4-b]pyridine
• Synonyms: 5-BroMo-2-chloro-thiazolo[5,4-b]pyridine;5-Bromo-2-Chlorothiazolo[5,4-B]Pyridine(WXC01944)
• CAS NO: 1355241-50-7
• Molecular Formula: C6H2BrClN2S
• Molecular Weight: 249.51548
• Mol File: 1355241-50-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BroMo-2-chloro-thiazolo[5,4-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BroMo-2-chloro-thiazolo[5,4-b]pyridine(1355241-50-7)
• EPA Substance Registry System: 5-BroMo-2-chloro-thiazolo[5,4-b]pyridine(1355241-50-7)

Safety Data

• Hazardous Substances Data: 1355241-50-7(Hazardous Substances Data)

Upstream product

• 169833-70-9 6-bromo-2-chloropyridine-3-ylamine 
• 934266-82-7 5-bromothiazolo[5,4-b]pyridin-2-amine 
• 13534-97-9 6-bromopyridine-3-amine 

Relevant articles and documents

FUSED AZOLE HETEROCYCLES AS AHR ANTAGONISTS

The present disclosure relates to thiazolo-pyridine, oxazolo-pyridine, pyrrolo-pyridine, pyrrolo-pyrazine and pyrrolo-pyrimidine compounds and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, methods of preparing

HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I) or (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

NOVEL COMPOUNDS AS GPR119 AGONISTS

The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.